Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2021

Nov 4, 2021

30442_dirs_2021-11-04_817020b2-f11c-412a-98b1-395f80016818.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-11-02

Reporting Person: Brady Kevin M. (CFO & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-02 Common Stock M 1250 $90.65 Acquired 6250 Direct
2021-11-02 Common Stock S 1250 $226.5 Disposed 5000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-02 Employee Stock Option (Right to Buy) $90.65 M 1250 Disposed 2024-08-05 Common Stock (1250) Direct

Footnotes

F1: Each option vested on August 5, 2019.